 | Aminoglutethimide | IC50 | 9000.0 [1] |
 | Aminoglutethimide | Ki | 680.0 [1] |
 | Fadrozole | IC50 | 30.0 [1] |
 | Fadrozole | Ki | 0.05 [1], 0.6 [2], 1.5 [3] |
 | Letrozole | IC50 | 5.3 [1] |
 | Letrozole | Ki | 0.02 [1], 2.2 [2] |
 | Formestane | IC50 | 370.0 [1] |
 | Formestane | Ki | 27.0 [1], 43.0 [2], 50.0 [3], 54.0 [4], 542.0 [5] |
 | Androst-4-en-17-one | IC50 | 110.0 [1] |
 | Androst-4-en-17-one | Ki | 6.8 [1] |
 | Ketoconazole | IC50 | 1300.0 [1] |
 | Ketoconazole | Ki | 398.11 [1] |
 | Anastrozole | IC50 | 8.0 [1] |
 | Anastrozole | Ki | 0.13 [1] |
 | Naringenin | IC50 | 1000.0 [1] |
 | Biochanin A | IC50 | 34000.0 [1] |
 | Biochanin A | Ki | 12000.0 [1] |
 | Androsta-1,4-diene-3,17-dione | IC50 | 530.0 [1] |
 | Androsta-1,4-diene-3,17-dione | Ki | 43.0 [1], 120.0 [2], 260.0 [3] |
 | Exemestane | IC50 | 42.5 [1], 50.0 [2], 230.0 [3], 900.0 [4] |
 | Exemestane | Ki | 10.2 [1], 26.0 [2] |
 | Rogletimide | IC50 | 5000.0 [1], 10000.0 [2], 45000.0 [3] |
 | Rogletimide | Ki | 1100.0 [1], 14000.0 [2] |
 | 2H-1-Benzopyran-2-one, 4-(1H-imidazol-1-ylmethyl)-7-phenoxy- | IC50 | 51.0 [1] |
 | 4-Imidazol-1-ylmethyl-1-nitro-xanthen-9-one | IC50 | 40.0 [1] |
 | 3-Ethyl-1-n-octyl-3-(4-pyridyl)piperidine-2,6-dione | IC50 | 800.0 [1], 5000.0 [2], 9000.0 [3] |
 | 3-Ethyl-1-n-octyl-3-(4-pyridyl)piperidine-2,6-dione | Ki | 120.0 [1], 480.0 [2] |
 | Resveratrol | IC50 | 25000.0 [1], 25400.0 [2] |
 | Resveratrol | Ki | 41670.0 [1] |
 | Chrysin | IC50 | 1.0 [1], 500.0 [2], 800.0 [3], 1500.0 [4] |
 | Chrysin | Ki | 2600.0 [1] |
 | E-Norendoxifen | IC50 | 76.8 [1], 90.0 [2], 102.0 [3] |
 | E-Norendoxifen | Ki | 48.0 [1] |
 | 19-Hydroxy-4-androsten-17-one | IC50 | 49.0 [1], 270.0 [2] |
 | 19-Hydroxy-4-androsten-17-one | Ki | 5.8 [1], 12.5 [2], 13.0 [3] |
 | 3alpha,4alpha-Epoxy-5alpha-androstan-17-one | IC50 | 145.0 [1], 180.0 [2] |
 | 3alpha,4alpha-Epoxy-5alpha-androstan-17-one | Ki | 38.0 [1] |
 | (7R,8R,9S,10R,13S,14S)-10,13-Dimethyl-7-prop-2-enyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-dione | IC50 | 470.0 [1] |
 | (7R,8R,9S,10R,13S,14S)-10,13-Dimethyl-7-prop-2-enyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-dione | Ki | 45.0 [1] |
 | (8R,9S,10S,13S,14S)-10-(Hydroxymethyl)-13-methyl-1,2,3,4,7,8,9,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-one | IC50 | 6900.0 [1] |
 | (8R,9S,10S,13S,14S)-10-(Hydroxymethyl)-13-methyl-1,2,3,4,7,8,9,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-one | Ki | 1000.0 [1] |
 | Androstenedione | IC50 | 260.0 [1], 300.0 [2] |
 | Androstenedione | Ki | 20.0 [1], 35.0 [2] |
 | Apigenin | IC50 | 900.0 [1], 1000.0 [2], 1200.0 [3], 10000.0 [4] |
 | Flavanone | IC50 | 8000.0 [1], 28000.0 [2], 28500.0 [3] |
 | 4-[(5r)-5,6,7,8-Tetrahydroimidazo[1,5-A]pyridin-5-Yl]benzonitrile | IC50 | 680.0 [1], 794.33 [2], 2290.87 [3], 6000.0 [4] |
 | Fadrozole hydrochloride | IC50 | 0.03 [1], 6.4 [2], 30.0 [3] |
 | Fadrozole hydrochloride | Ki | 1.5 [1] |
 | Rivizor | IC50 | 1.38 [1], 1.41 [2], 29.0 [3], 44.2 [4] |
 | Plomestane | IC50 | 56.2 [1] |
 | Plomestane | Ki | 4.0 [1], 6.2 [2], 15.2 [3] |
 | YM511 (pharmaceutical) | IC50 | 0.12 [1], 0.5 [2] |
 | Norendoxifen | IC50 | 30.0 [1], 1029.0 [2] |
 | Norendoxifen | Ki | 442.0 [1] |
 | Androst-5-en-17-one | IC50 | 660.0 [1] |
 | Androst-5-en-17-one | Ki | 120.0 [1] |
 | 4-(1H-Imidazol-1-ylmethyl)benzonitrile | IC50 | 7.0 [1], 15.0 [2], 1096.48 [3], 1200.0 [4] |
 | 4-[4-Cyanophenyl(1H-1-imidazolyl)methyl]benzonitrile | IC50 | 3.0 [1], 3.5 [2], 4.0 [3], 18.2 [4] |
 | 4-Bromo-1-imidazol-1-ylmethyl-xanthen-9-one | IC50 | 933.25 [1], 940.0 [2] |
 | 3-((1H-Imidazol-1-yl)methyl)-9H-xanthen-9-one | IC50 | 389.05 [1], 390.0 [2] |
 | 2-Phenyl-7-methoxy-3-(1H-imidazole-1-ylmethyl)chromone | IC50 | 549.54 [1], 550.0 [2] |
 | 1-Imidazol-1-ylmethyl-9-oxo-9H-xanthene-4-carbonitrile | IC50 | 2290.87 [1], 2300.0 [2] |
 | 1-Imidazol-1-ylmethyl-4-nitro-xanthen-9-one | IC50 | 970.0 [1], 977.24 [2] |
 | (7Z)-6-(4-Chlorophenyl)-7-(pyridin-4-ylmethylidene)-5,6-dihydroindolizin-8-one | IC50 | 150.0 [1], 200.0 [2] |
 | (7Z)-6-(4-Chlorophenyl)-7-(pyridin-4-ylmethylidene)-5,6-dihydroindolizin-8-one | Ki | 10.3 [1] |
 | 4-Imidazol-1-ylmethyl-9-oxo-9H-xanthene-1-carbonitrile | IC50 | 42.66 [1], 43.0 [2] |
 | 1-Ethyl-5-((4-fluorophenyl)(1H-imidazol-1-yl)methyl)-1H-indole | IC50 | 40.0 [1], 41.0 [2] |
 | 7-Benzyloxy-4-(1H-imidazol-1-ylmethyl)-2H-chromen-2-one | IC50 | 150.0 [1], 151.36 [2] |
 | 2H-1-Benzopyran-2-one, 4-(1H-imidazol-1-ylmethyl)-7-methoxy- | IC50 | 280.0 [1], 281.84 [2] |
 | 3-(Naphthalen-2-yl)pyridine | IC50 | 2000.0 [1], 5700.0 [2], 5727.0 [3] |
 | 7-(Benzyloxy)-3-phenyl-2-[(pyridin-4-ylmethyl)sulfanyl]-4H-chromen-4-one | IC50 | 210.0 [1], 210000.0 [2] |
 | 7-(Benzyloxy)-3-phenyl-2-[(pyridin-4-ylmethyl)sulfanyl]-4H-chromen-4-one | Ki | 220.0 [1] |
 | (3As,3bR,9aR,9bS,11aS)-9a,11a-dimethyl-3,3a,3b,4,5,9b,10,11-octahydronaphtho[2,1-e][2]benzofuran-1,7-dione | Ki | 260.0 [1], 390.0 [2], 410.0 [3] |
 | 3-Capabh | IC50 | 12.0 [1], 150.0 [2], 230.0 [3], 780.0 [4] |
 | 3-n-Octyl-3-(4-pyridyl)piperidine-2,6-dione | IC50 | 330.0 [1], 600.0 [2] |
 | 3-n-Octyl-3-(4-pyridyl)piperidine-2,6-dione | Ki | 90.0 [1], 200.0 [2] |
 | 1-(4-Aminophenyl)-3-azabicyclo[3.1.0]hexane-2,4-dione | IC50 | 1800.0 [1], 7000.0 [2], 11000.0 [3] |
 | 1-(4-Aminophenyl)-3-azabicyclo[3.1.0]hexane-2,4-dione | Ki | 1200.0 [1] |
 | 1-(4-Amino-phenyl)-3-pentyl-3-aza-bicyclo[3.1.0]hexane-2,4-dione | IC50 | 23.0 [1], 85.0 [2], 140.0 [3] |
 | 1-(4-Amino-phenyl)-3-pentyl-3-aza-bicyclo[3.1.0]hexane-2,4-dione | Ki | 20.0 [1] |
 | 2-(1H-Imidazol-1-yl)-7-methoxy-3-phenyl-4H-chromen-4-one | IC50 | 770.0 [1], 776247116628.69 [2] |
 | 2-(1H-Imidazol-1-yl)-7-methoxy-3-phenyl-4H-chromen-4-one | Ki | 680.0 [1] |
 | 2-(1H-Imidazol-1-yl)-7-methoxy-3-(4-methoxyphenyl)-4H-chromen-4-one | IC50 | 2000.0 [1], 1949844599758.04 [2] |
 | 2-(1H-Imidazol-1-yl)-7-methoxy-3-(4-methoxyphenyl)-4H-chromen-4-one | Ki | 1820.0 [1] |
 | 7-(Benzyloxy)-2-(1H-imidazol-1-yl)-3-phenyl-4H-chromen-4-one | IC50 | 520.0 [1], 512861383991.37 [2] |
 | 7-(Benzyloxy)-2-(1H-imidazol-1-yl)-3-phenyl-4H-chromen-4-one | Ki | 250.0 [1] |
 | 7-(Benzyloxy)-2-(1H-imidazol-1-yl)-3-(4-methoxyphenyl)-4H-chromen-4-one | IC50 | 4700.0 [1], 4677351412871.98 [2] |
 | 7-(Benzyloxy)-2-(1H-imidazol-1-yl)-3-(4-methoxyphenyl)-4H-chromen-4-one | Ki | 4400.0 [1] |
 | (E/Z)-N,N-Didesmethyl-4-hydroxy Tamoxifen | IC50 | 90.0 [1], 102.2 [2] |
 | (E/Z)-N,N-Didesmethyl-4-hydroxy Tamoxifen | Ki | 77.0 [1] |
 | Xolegel | IC50 | 951.48 [1], 1600.0 [2], 2600.0 [3] |
 | Nizoral | IC50 | 16000.0 [1], 110000.0 [2] |
 | Nizoral | Ki | 65000.0 [1] |
 | Flavone | IC50 | 8.0 [1], 8000.0 [2], 10000.0 [3] |
 | alpha-Naphthoflavone | IC50 | 70.0 [1], 2000.0 [2] |
 | alpha-Naphthoflavone | Ki | 20.0 [1] |
 | Abiraterone | IC50 | 5000.0 [1], 20000.0 [2], 50000.0 [3] |
 | Osilodrostat | IC50 | 856.0 [1], 1584.89 [2], 6000.0 [3] |
 | 7-Methoxyflavanone | IC50 | 8000.0 [1] |
 | 7alpha-Apta | Ki | 18.0 [1] |